Engineered humanized dimeric forms of IgG are more effective antibodies.
about
A fusion protein composed of receptor binding domain of vascular endothelial growth factor-A and constant region fragment of antibody: angiogenesis antagonistic activity.Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells.Antibody-based therapies as anti-infective agents.The biological therapy of acute and chronic leukemia.IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
P2860
Engineered humanized dimeric forms of IgG are more effective antibodies.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Engineered humanized dimeric forms of IgG are more effective antibodies.
@ast
Engineered humanized dimeric forms of IgG are more effective antibodies.
@en
type
label
Engineered humanized dimeric forms of IgG are more effective antibodies.
@ast
Engineered humanized dimeric forms of IgG are more effective antibodies.
@en
prefLabel
Engineered humanized dimeric forms of IgG are more effective antibodies.
@ast
Engineered humanized dimeric forms of IgG are more effective antibodies.
@en
P2093
P2860
P356
P1476
Engineered humanized dimeric forms of IgG are more effective antibodies.
@en
P2093
P2860
P304
P356
10.1084/JEM.176.4.1191
P407
P577
1992-10-01T00:00:00Z